AQIX RS-I - Basic development of a therapeutic formulation for the assessment and regeneration of donor organs otherwise regarded as marginal for transplantation

AQIX RS-I - 用于评估和再生供体器官的治疗制剂的基本开发，否则被视为移植的边缘

• 批准号: 130312
• 金额: $ 37.28万
• 依托单位: AQIX LIMITED
• 依托单位国家: 英国
• 项目类别: Fast Track
• 财政年份: 2010
• 资助国家: 英国
• 起止时间: 2010 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=130312
• 关键词: AQIX; RS; Basic; development; therapeutic

Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.

目前GtR中并没有所有资助研究的摘要。这通常是因为在提交提案时不需要摘要，但也可能是因为摘要中包含个人详细信息等敏感信息。